WO2003008011A1 - Revetement reticule multipolymere - Google Patents

Revetement reticule multipolymere Download PDF

Info

Publication number
WO2003008011A1
WO2003008011A1 PCT/US2002/013194 US0213194W WO03008011A1 WO 2003008011 A1 WO2003008011 A1 WO 2003008011A1 US 0213194 W US0213194 W US 0213194W WO 03008011 A1 WO03008011 A1 WO 03008011A1
Authority
WO
WIPO (PCT)
Prior art keywords
article
coating
monomers
polyfunctional
acrylamide
Prior art date
Application number
PCT/US2002/013194
Other languages
English (en)
Inventor
John Charkoudian
Original Assignee
Millipore Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millipore Corporation filed Critical Millipore Corporation
Priority to DE60212965T priority Critical patent/DE60212965T2/de
Priority to EP02729002A priority patent/EP1390087B1/fr
Priority to JP2003513615A priority patent/JP4192091B2/ja
Publication of WO2003008011A1 publication Critical patent/WO2003008011A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0076—Chemical modification of the substrate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2323/00—Details relating to membrane preparation
    • B01D2323/30—Cross-linking

Definitions

  • the present invention relates to the field of articles having a surface coating.
  • the surface coating comprises a cross-linked multipolymer which has a superior combination of properties, including heat stable biomolecule resistant adsorptive properties, resistance to strong alkaline solutions, and low levels of extractable matter.
  • Solutions that contain biological molecules are used in myriad applications in scientific and commercial settings.
  • One problem encountered in handling such solutions is the adsorption of biomolecules onto fluid-contacting surfaces.
  • Such adsorption can lead to fouling of liquid transporting lines, and to contamination of solutions.
  • such adsorption can lead to bacterial growth on surfaces, which is highly undesirable.
  • a further important property of materials used for devices that contact solutions containing biological molecules, and especially medical devices, is biocompatibility; i.e., the ability to minimize or resist adverse effects on biological tissues at the material interface.
  • biocompatibility i.e., the ability to minimize or resist adverse effects on biological tissues at the material interface.
  • One important aspect of such biocompatibility is the ability to resist the adsorption of biological molecules, and particularly proteins, when contacted with tissues and biological solutions such as blood, plasma, and tear fluids.
  • Such resistance is of critical importance, particularly in medical devices, because minimizing the adsorption of proteins and other biomolecules reduces the adhesion of cells and cellular components that can compromise the proper functioning of such devices.
  • the present invention provides articles having a surface coating, said coating comprising a crosslinked multipolymer, said crosslinked multipolymer comprising: at least one polyfunctional monomer selected from the group consisting of polyfunctional acrylamides, polyfunctional methacrylamides, and diacroylpiperazines; and at least two mono functional monomers selected from the group consisting of acrylamides, methacrylamides, and N-vinyl pyrrolidones.
  • Also provided in accordance with the present invention are methods for the preparation of an article having a biomolecule resistant surface coating, said method comprising the steps of: (a) providing an article having a surface;
  • At least two monofunctional monomers selected from the group consisting of acrylamides, methacrylamides, and N-vinyl pyrrolidones;
  • the crosslinked multipolymer comprises at least one monofunctional monomer that is acrylamide, wherein the acrylamide nitrogen of said acrylamide is substituted with at least one gem dialkyl substituted carbon.
  • the crosslinked multipolymer is a copolymer formed from dimethylacrylamide, diacetone acrylamide, and methylene-bis-acrylamide. In still further embodiments, the crosslinked multipolymer is a copolymer formed from methylene-bis-acrylamide, N-vinyl pyrrolidone, and either of dimethylacrylamide or diacetone acrylamide.
  • the biomolecule resistant polymer coating is a separately formed surface coating; said surface coating comprising a crosslinked multipolymer; said crosslinked multipolymer comprising: at least one polyfunctional monomer selected from the group consisting of polyfunctional acrylamide monomers, polyfunctional methacrylamide monomers, and diacroylpiperazines; and at least two different monofunctional monomers selected from the group of N-vinyl pyrrolidone monomers and monomers having the Formula I:
  • R 1 is H or CH 3 ,
  • R 2 is H or Cj-C ⁇ , preferably C ⁇ -C 3 alkyl, either linear or branched
  • R is H or Ci-C ⁇ , preferably C ⁇ -C alkyl, either linear or branched, or
  • the crosslinked multipolymer further comprises a supplemental property modifying monomer, which can be (3- (methacryloylamino)propyl)trimethylammonium chloride, (3- acrylamidopropyl)trimethylammonium chloride, 2-acrylamido-2-methyl- 1 - propanesulfonic acid or aminopropylmethacrylamide.
  • a supplemental property modifying monomer which can be (3- (methacryloylamino)propyl)trimethylammonium chloride, (3- acrylamidopropyl)trimethylammonium chloride, 2-acrylamido-2-methyl- 1 - propanesulfonic acid or aminopropylmethacrylamide.
  • two of the monofunctional monomers are present in the ratio of about 1 to about 5 by weight, or in the molar ratio of about 1 to about 2.
  • the total amount of the monofunctional monomers present is from about 0.5% to about 20% by weight, or from about 2% to about 10%, or from about 4% to about 8% by weight.
  • the ratio of the total amount of monofunctional comonomers to polyfunctional crosslinker monomer is about 1 to about 10 by weight, or about 2 to about 6 by weight.
  • the polymer coating is hydrophilic. In further embodiments, the coating is a hydrogel.
  • the polymer coating has a biomolecule binding of less than about 30 microgram per square centimeter measured by the IgG binding test for porous articles, and less than about 0.30 microgram per square centimeter measured by the IgG binding test for nonporous articles.
  • the polymer coating has TOC extractables of less than about 1 microgram of extractable matter per square centimeter of coating as measured by the TOC Extractables test for porous articles, or less than about 0.01 microgram of extractable matter per square centimeter of coating as measured by the TOC Extractables test for nonporous articles.
  • the polymer coating has TOC extractables of less than about 2 micrograms of extractable matter per square centimeter of coating as measured by the NVR Extractables test for porous articles, or less than about 0.02 micrograms of extractable matter per square centimeter of coating as measured by the NVR Extractables test for porous articles.
  • the polymer coating is caustic resistant. In some further embodiments, the polymer coating has caustic resistance of less than about 1.3 as measured by the Flow Time Measurement test.
  • the article is an article of labware, a medical article, a beverage fluid container or conduit, a marine article, or a plumbing article.
  • the article is cuvette, a cuvette cap, a round, conical or cylindrical flask, a beaker, a centrifuge tube, a centrifuge bottle, a chromatography column, a cylinder, a graduated cylinder, an incubation chamber, a fermentation chamber, a pipette, a replaceable pipette tip, a multiwell plate, a weighing boat, a media filter, dialysis tubing, laboratory tubing, pump tubing, a syringe, a syringe needle, a burette, a molds for electrophoresis tubes or gels, an electrophoresis apparatuses, a blotter, a sequencer, a gel staining tray, a filter unit, a funnel, a hybridization tube, a shaker flask, a cell culture flask, a cell culture tube, a culture vessel, a culture dish, a cloning
  • the article is a medical article, which can be a biosensor, an implant, a catheter, a wound dressing, a contact lense, an implantable lens or a dermal patch.
  • the article is a beverage fluid container or conduit, or a marine article, which can be boat, or an article of boating equipment.
  • the article is an aquarium, an aquarium article, or an article of plumbing.
  • Also provided in accordance with the present invention are methods for increasing the biocompatibility of an article comprising the step of coating at least one surface of said article, said coating comprising a crosslinked multipolymer, said crosslinked multipolymer comprising: at least one polyfunctional monomer selected from the group consisting of polyfunctional acrylamides, polyfunctional methacrylamides, and diacroylpiperazines; and at least two monofunctional monomers selected from the group consisting of acrylamides, methacrylamides, and N-vinyl pyrrolidones.
  • Figure 1 shows the levels of extractable material as total organic carbon for membranes of the prior art, and of the present invention, after different soak times.
  • Figure 2 illustrates the effect of heat on the resistance to biomolecule adso ⁇ tion of membranes of the present invention.
  • the present invention provides porous and non-porous articles having a surface coating.
  • the surface coatings of the invention have one or more desirable properties, including resistance to biomolecule adso ⁇ tion (sometimes referred to as “low affinity or sorbability for biomolecules” or “biomolecule resistance”), heat stable resistance to such biomolecule adso ⁇ tion, chemical resistance to strong alkaline solutions such as are used to clean and/or sanitize articles, and very low levels of extractable matter.
  • the present invention provides articles which have a crosslinked multipolymer surface, which, in some embodiments, is formed situ on the surface of the article, and which has superior biomolecule resistance.
  • biomolecule is intended to mean any organic molecule that is part of a living organism, or analogs thereof.
  • biomolecules include polymers of amino acids, for example peptides and proteins (including antibodies and enzymes), and polymers of nucleotides such as DNA and RNA, and oligonucleotides, including for example DNA and RNA probes.
  • carbohydrates and lipids are also included within the definition of biomolecules.
  • biomolecule resistant or “biomolecule resistance” as applied to coatings, coated article surfaces or methods of the invention mean, for a nonporous article surface (for example a smooth article surface that has been coated with a coating of the invention), such a surface that adsorbs less than about 0.30 micrograms of IgG per square centimeter of surface area as measured by the IgG binding test described herein.
  • a biomolecule resistant surface is one which adsorbs less than about 30 micrograms of IgG per square centimeter of surface area as measured by the IgG binding test described herein.
  • the terms "biomolecule resistant” or “biomolecule resistance” as applied to coatings, coated article surfaces or methods of the invention mean surfaces or surface coatings which provide a negative BSA-Ponseau test as described herein. Because the surface coated articles of the invention have superior biomolecule resistance, the articles of the invention also possess superior biocompatibility.
  • biomolecules and in particular, proteins.
  • the ability of a surface to resist adso ⁇ tion of proteins is generally a prerequisite for the ability of a surface to resist attachment of bacteria and mammalian cells (see, for example, Ostuni, E. et a ⁇ .,Langmuir, 2001, 17, 6336-6343).
  • the ability to resist the adso ⁇ tion of biomolecules conferred by the coatings of the present invention are also expected to impart significantly increased biocompatibility to articles of the invention.
  • the surface coatings of the present invention provide a biomolecule resistant surface which also is heat stable.
  • heat stable as applied to coatings, coated article surfaces or methods of the invention means that the surface, after exposure to heat as described herein, has less than about twice the IgG adso ⁇ tion of the same surface prior to heat exposure, as measured by the IgG test described herein.
  • the surface coatings of the invention provide a biomolecule resistant surface that also is caustic resistant.
  • the term "caustic resistant” or “caustic resistance” as applied to coatings, coated article surfaces or methods of the invention means a surface coating that remains wettable after exposure to 0.1 NaOH for two hours at ambient temperature.
  • “caustic resistance” alternatively means a ratio of flow times after such exposure to that before such exposure of less than about 1.5, when measured by the flow time measurement test described herein.
  • the surface coatings of the invention provide a biomolecule resistant surface that also is clean.
  • the term "clean” or “clean article surface coating” means an article surface coating that, when produced, has for a nonporous surface either a. less than about 0.02 micrograms of extractable matter per square centimeter of coated surface, and preferably less than about 0.01 microgram of extractable matter per square centimeter, as determined by the NVR Extraction test described herein; or b. less than about 0.01 microgram of extractable matter per square centimeter of article surface coating as determined by the TOC extractables test described herein; Or, for a porous surface, has either: a. less than about 2 micrograms of extractable matter per square centimeter of coated surface, and preferably less than about 1 microgram of extractable matter per square centimeter, as determined by the NVR
  • the surface coatings of the invention are separately formed in situ, and have one or more of the properties described above.
  • articles of the invention can be modified as described herein to contain the surface coatings of the invention. These include, without limitation, articles of labware, medical articles, beverage fluid containers or conduits, a marine articles, and plumbing articles. Further examples, without limitation, of such articles include those composed of ceramics, metals, carbon, polymers and combinations thereof. In some preferred embodiments, articles of the invention are composed of polymers or ceramics.
  • Representative polymers that can be used to manufacture articles which can be modified with the surface coatings of the invention include polysulfone polymers, preferably aromatic sulfone polymers, such as polysulfone and polyethersulfone polymers, perfluorinated thermoplastic polymers including polytetrafluoroethylene and polyvinylidene fluoride, polyolefin polymers such as polyethylene, ultrahigh molecular weight polyethylene and polypropylene, and polyesters such as polyethyleneterepthalate, polycarbonate, plasticized and nonplasticized polyvinyl chloride, and other thermoplastic polymers useful in applications where biological samples are contained or transported.
  • polysulfone polymers preferably aromatic sulfone polymers, such as polysulfone and polyethersulfone polymers, perfluorinated thermoplastic polymers including polytetrafluoroethylene and polyvinylidene fluoride, polyolefin polymers such as polyethylene, ultrahigh molecular weight polyethylene and polypropylene, and polyester
  • the article surface to be coated is a polymer of PVDF, polyolefin or Nylon, and derivatives.
  • Those skilled in the art will readily be able to identify other polymers useful in the formation of articles capable of being modified with the surface coatings of the invention.
  • the surface coatings of the invention can be applied to articles in several forms, including without limitation polymer coatings which have the ability to be highly hydrated, such as hydrogels, and coatings which have limited or no ability to be hydrated.
  • polymer coatings which have the ability to be highly hydrated such as hydrogels
  • coatings which have limited or no ability to be hydrated are known in the art.
  • a hydrogel coating according to the invention one would select monomers that have a high capacity bind water, as are known in the art.
  • a suitable hydrogel can be prepared by combining 7 grams acrylamide, 1 gram methylenebisacrylamide, 0.2 grams Irgacure
  • porous articles articles in which the porosity is through-going, so that fluids can transverse the membrane or article thickness.
  • the term "surface" as applied to the surface coatings of the membrane or other similarly porous article means the entire surface area of such article that is coated with a coating of the invention, including external surfaces (i.e., surfaces not within the thickness of the membrane) and interstitial surfaces within the thickness of the membrane.
  • the term "surface" as applied to the surface coatings of the articles coated with the surface coatings of the invention means the surface of the article which is accessible to the solution used to coat the article.
  • Such surfaces can include those open to view (for example the surface of a laboratory weighing boat), and those hidden from view, but which are nevertheless "external" surfaces of the article, for example the lumen of a catheter, the interior of a conduit or of tubing, or a cavity of an article regardless whether it is accessible to view.
  • crosslinked multipolymer means a polymer made from three or more monomers, of which at least one monomer has two or more reactive sites which can take part in a polymerization reaction, or can crosslink separate polymer chains.
  • multipolymers contain at least three different monomers, and can also contain one or more additional monomers to impart or refine desired properties of the surface coating.
  • the crosslinked multipolymer is made from two monofunctional monomers and one difunctional monomer.
  • the crosslinked multipolymer covers the entire surface of the article that is to be coated.
  • the crosslinked multipolymer is formed in situ from a solution of two or more monofunctional monomers and a crosslinking polyfunctional monomer (referred to herein as the "reactant solution").
  • a monofunctional monomer is one that has a single unsaturated functional group.
  • Polyfunctional monomers are molecules which have more than one unsaturated functional group.
  • two or more of the monofunctional monomers are mono- or di-N-substituted acrylamides or methacrylamides.
  • the crosslinking monomer is a polyfunctional acrylamide or methacrylamide.
  • dimethylacrylamide and diacetone acrylamide are used with methylene-bis-acrylamide.
  • N-vinyl pyrrolidone is substituted for one of the mono- or di-N-substituted acrylamide or methacrylamide monofunctional monomers.
  • at least one polyfunctional monomer is a polyfunctional acrylamide monomer, a polyfunctional methacrylamide monomer, or a diacroylpiperazine, and at least two different monofunctional monomers are selected from acrylamide monomers, methacrylamide monomers, and N-vinyl-pyrrolidones.
  • At least one polyfunctional monomer is a polyfunctional acrylamide monomer, a polyfunctional methacrylamide monomer, or a diacroylpiperazine, and at least two different monofunctional monomers are selected from N-vinyl pyrrolidone monomers and monomers having the general Formula I:
  • the crosslinked multipolymer is a polymer formed from either:
  • Also provided in accordance with some embodiments of the present invention are methods for the preparation of an article having a biomolecule resistant surface coating, said method comprising the steps of:
  • At least two monofunctional monomers selected from the group consisting of acrylamides, methacrylamides, and N-vinyl pyrrolidones;
  • the entire surface of the article to be coated is coated with the multipolymer.
  • the reactant solution should preferably wet the entire surface to be coated. This is preferably facilitated by performing a washing step prior to contacting the surface of the article with the reactant solution.
  • the surface of the article is first washed with a washing liquid which completely wets the entire surface to be coated.
  • the washing liquid can preferably be exchanged with the reactant solution.
  • the wetting liquid can be an organic-water composition having lower surface tension than the surface tension required to wet the article surface.
  • suitable wetting liquids are alcohol-water solutions, preferably methanol-water, ethanol-water, or isopropanol-water solutions.
  • a second washing step can be used to remove the washing liquid and replace the same with a second washing liquid that does not interfere with the polymerization or crosslinking reactions.
  • a second washing step can be used to remove the washing liquid and replace the same with a second washing liquid that does not interfere with the polymerization or crosslinking reactions.
  • the wet article surface is washed with water to remove the first wetting liquid and produce a water filled or water-wet article surface.
  • the wet article surface is then contacted with the reactant solution (for example by soaking in the reactant solution or applying the reaction solution to the surface to be coated) to produce the desired reactant composition in the article surface.
  • the first and second washing steps are performed at ambient temperatures, for instance, 20°C to 30°C, and preferably for times from a few seconds to a few minutes.
  • the reactant solution wets the article surface sufficiently, due to containing an organic solvent for that pu ⁇ ose, or if the concentration of reactants in the reactant solution is sufficient to lower the surface tension of the solution to allow the reactant solution to fully wet the article surface, then neither of the washing steps are required.
  • the reactant solution will contain one or more additives which lower the surface tension of the reactant solution sufficiently to avoid such washing steps, and which do not interfere with the subsequent polymerization reaction.
  • additives include ethyl hexyl diol, propylene carbonate, tripropyleneglycol methyl ether and 2-methyl-2,4-pentane diol.
  • the amount of additive to the reactant solution required to achieve proper wetting depends on the amount and type of monomers and initiators being used, and will be readily determinable by those of skill in the art without undue experimentation.
  • the reactant solution includes solvent, monofunctional monomers, at least one polyfunctional crosslinking monomer, and, optionally, one or more initiators.
  • the choice of solvent for the reactant solution depends on the choice of monomers and optional initiators.
  • the solvent preferably (1) dissolves the reactants and, if present, the initiator; (2) does not interfere or hinder the polymerization reaction; and (3) does not attack the article surface.
  • a particularly preferred solvent is water.
  • the multipolymer is formed from at least two monofunctional monomers chosen from acrylamides, methacrylamides, or N-vinyl pyrrolidones, and at least one polyfunctional acrylamide or methacrylamide crosslinking monomer.
  • monomers chosen from acrylamides, methacrylamides, or N-vinyl pyrrolidones, and at least one polyfunctional acrylamide or methacrylamide crosslinking monomer.
  • other monomers may be used. These include N-vinyl pyrrolidones, and other mono- or di-N-substituted acrylamide or methacrylamide monomers, for example those having the Formula I as described supra.
  • the ratio of a first monofunctional comonomer to a second monofunctional comonomer be from about 1 to 5, more preferably from about 1 to 2.
  • the total amountof comomomers is from about 0.5% to about 20%, more preferably between about 2% to about 10%, and still more preferably from about 45 to about 8%.
  • the multipolymer can contain one or more monofunctional monomers in addition to the two monofunctional monomers previously described. Such additional monofunctional monomers can be advantageously employed to impart or modify specific properties of the multipolymer.
  • a third monofunctional monomer having a different functionality from the other two monofunctional monomers it is preferable to include a third monofunctional monomer having a different functionality from the other two monofunctional monomers to effect the modification.
  • additional monomers are employed in a minor amount, or an amount comparable to the monofunctional monomers.
  • Representative additional property modifying monomers include can be(3-(methacryloylamino)propyl)- trimethylammonium chloride, (3-acrylamidopropyl)trimethylammonium chloride, 2- acrylamido-2-methyl-l-propanesulfonic acid and aminopropylmethacrylamide
  • the multipolymer contains at least one polyfunctional crosslinker monomer (or "crosslinking monomer"). While not wishing to be bound by a particular theory, it is believed that the crosslinking monomer facilitates a permanent modification to the article surface by, inter alia, both participating in the chain polymerization reactions, and by crosslinking the polymerized chains of monofunctional monomer.
  • preferred crosslinking monomers suitable for use in the present invention include polyfunctional acrylamides, polyfunctional methacrylamides, and diacroylpiperazine, with polyfunctional acrylamides, and polyfunctional methacrylamides being more preferred.
  • Ethylene-bis-acrylamide and methylene-bis-acrylamide are particularly preferred crosslinking monomers, with methylene-bis-acrylamide being especially preferred.
  • the ratio of amount of crosslinker monomer to the total amount of monofunctional monomers present in the multipolymer is from about 1 to about 10, more preferably from about 2 to about 6.
  • the terms "monomer” and “comonomer” shall be used interchangeably.
  • the polymerization of the monofunctional monomers and the crosslinking copolymer or copolymers of the present invention is achieved through free radical initiation and propagation.
  • one or more free radical initiators can be included in the in the reactant solution containing the monomers to facilitate polymerization. Any of a wide variety of initiators known in the art will find applicability in the present invention.
  • the initiator or initiators are water soluble. In other preferred embodiments, for example when wetting reactant solutions are used, sparingly water soluble initiators are preferred.
  • suitable initiators include, for example, ammonium persulfate, potassium persulfate, azobis(4-cyanovaleric acid, Irgacure 2959 (Ciba-Geigy, Hawthorn, NY), 2,2'-azobis(2-amidino-propane)hydrochloride and the like.
  • the initiator or initiators are used in the range of from about 0.1% to about 1% by weight, based on the total reactant solution.
  • the surface of the article to be coated is contacted with (i.e., is saturated with) the reactant solution, excess reactant solution removed from the external surfaces, while still leaving such external surfaces wetted with solution.
  • polymerization of the reactant solution is then begun by exposing the wet article surface to any conventional energy source, such as heating, ultraviolet light, electron beam or gamma radiation.
  • Free radical polymerization initiated by heat is typically achieved by heating the saturated media or membrane to at least about 60°C and maintaining that temperature for from about 0.1 to about 10 minutes, preferably between about 1 to about 2 minutes. Higher temperatures can be used depending on the combination of initiator and monomers used, up to the point where boiling or too rapid vaporization adversely affects the polymerization reaction.
  • ultraviolet light is used to initiate the in situ polymerization reaction.
  • the article surface saturated with the reactant solution which optionally contains one or more initiators
  • an ultraviolet light source such as Fusion Systems F600 (Rockville, MD) with an "H" bulb.
  • Filters can be used to reduce or remove undesirable wavelengths which may cause unwanted damage to the porous media or membrane being modified.
  • electron beam technology is used to initiate polymerization, for example by facile adaptation of the methods described in U.S. Patent 4,944,879, the disclosure of which is inco ⁇ orated herein by reference.
  • an article wet with the reaction solution is passed through a curtain of electrons generated by an electron beam processor.
  • the processor delivers the desired dose at from about 100 kV to about 200 kV.
  • the article is transported at a speed suitable to give the desired exposure time under the curtain.
  • Exposure time, combined with dose determines the dose rate. Typical exposure times are from about 0.5 seconds to about 10 seconds. Dose rates generally are from 0.05 kGy (kiloGray) to about 5 kGy.
  • the amount of oxygen in the reaction zone be controlled to levels below about 200 ppm, preferably below about 50 ppm. In some preferred embodiments, this is accomplished by flooding the reaction zone with inert gas such as nitrogen or argon, or by other well known methods of excluding air.
  • the polymerization of the monomers of the reactant solution can be initiated by gamma irradiation.
  • an article that is wet with reaction solution is irradiated.
  • the reactant solution is degassed, that is, treated so as to remove air, and particularly oxygen, from the solution.
  • degassing is accomplished by replacing air with an inert gas such as helium, nitrogen or argon.
  • degassing is accomplished by reducing the pressure over the monomer solution, for example with a vacuum pump.
  • the degassed monomer solution laden article surface is then sealed with a sealing material so as to remain in a degassed state, and then irradiated at the desired dose.
  • a sealing material will not be degraded by the irradiation, and also does not significantly retard the gamma rays.
  • materials are known in the art to be useful as sealing materials, for example many plastics, especially films, and for flat planar surfaces, borosilicate glass.
  • total dosages of about 0.02 to about 1.0 kGy are suitable. Typical exposures of about 5 to about 500 kilorads per hour, more preferably about 5 to about 150 kilorads per hour can be used, with typical irradiation times of from about 4 to about 60 hours. Those of skill in the art will readily be able to determine the proper balance of dose rate and time to arrive at the total dosage.
  • the degree to which the crosslinked multipolymer is grafted (i.e., the degree to which the multipolymer is bound) to the article surface can be controlled by, inter alia, the choice of method of initiation the polymerization reaction. For example, gamma irradiation is generally expected to give a greater degree of grafting of the copolymer to a polymeric article surface, while heat induced initiation will have a lesser degree of grafting. Those of skill in the art will readily be able to select the initiation method that will give the desired degree of grafting of multipolymer to the article surface.
  • the methods of the invention are applicable to the fabrication of articles having a wide variety of surface topologies, including flat, rounded, conical, and tubular surfaces.
  • Coating methods are known from the textile fiber and monofilament industries which can be adapted to the methods of the invention to facilitate coating of articles.
  • the surface coatings of the invention find use in the modification of any article where fouling liquids, particularly those liquids containing biomolecules, can contaminate or accrue on liquid-contacting surfaces of the article.
  • the present invention provides coated articles of labware and methods of preparing such coated articles.
  • Articles of labware denotes articles used in laboratories that come in to contact with samples that contain biomolecules.
  • articles of labware includes cuvettes and caps therefor, round, conical or cylindrical flasks, beakers, centrifuge tubes and bottles, chromatography columns, cylinders and graduated cylinders, incubation and fermentation chambers, pipettes, replaceable pipette tips, and multiwell plates used in a wide variety of applications including, for example, assays.
  • weighing boats media filters, dialysis tubing, dispenser tubing, laboratory tubing, pump tubing, syringes, syringe needles, burettes, molds for electrophoresis tubes and gel, and electrophoresis apparatuses, blotters, sequencers, gel staining trays, filter units, funnels, hybridization tubes, shaker flasks, cell culture flasks and tubes, culture vessels, culture dishes (e.g. petri dishes) and other cultureware, cloning cylinders, and tissue culture media.
  • labware articles are known to be composed of a variety of materials, including but not limited to glass, plastics, ceramics, and metals, and each, without limitation, are withing the scope of the term labware. Further labware articles can readily be identified by those of skill in the art in Biochemicals and Reagents for Life Science Research (Sigma Co. Catalog) 2000-2001, Fisher Scientific Co. Catalog 2000/2001, and VWR Scientific Products Catalog 2000/2001, which are inco ⁇ orated herein by reference in their entirety.
  • the present invention provides coated medical articles and methods of preparing such coated articles.
  • the term "medical articles" is intended to include medical devices and fungibles that are used in or on the body of an animal, including but not limited to human, in connection with medical treatment, including, for example, surgery, examination, administration of medication, and the like.
  • medical devices include prostheses, sensors including biosensors, implants, catheters, wound dressings, contact lenses, artificial organs including but not limited to artificial hearts, implantable lenses for example for treatment of cataracts, and drug delivery devices including but not limited to dermal patches for delivering medication.
  • devices having surface coatings of the invention include those useful in the biotechnology industry, including preparative and diagnostic devices.
  • Examples of such devices include substrates for enzyme assays, including enzyme-linked immunosorbent assays, systems for patterned cell culture (see, for example, Chen, C.S., et al., Science 1997, 276, 1425-1428), tissue engineering (see, for example, Niklason, L.E., et al., Science 1999, 284, 489-493), materials used in microfluidic and analytical systems (see, for example, Microsystem Technology in Chemistry and Life Sciences, Manz., A. and Becker, Eds., Springer-Verlag Berlin-Helsinki 1998 (Top. Curr. Chem No. 194)), and systems for high throughput screening using proteins (see, for example, Macbeath, G.
  • nucleic acids and/or cells see, for example, Whitney, M., et al., Nat. Biotechnol. 1998, 1 1329-1333
  • devices which can beneficially inco ⁇ orate the surface coatings of the invention include hemodialyzers, artificial organs including artificial hearts, industrial and biomedical bioreatcors, and bioseparation devices. Further examples can be found in Biomaterials Science An Introduction to Materials in Medicine, Rattier, B.D., Schoen, F.J. and
  • the present invention provides coated beverage fluid containers and conduits, and methods for preparing such coated containers and conduits.
  • the term "beverage fluid containers and conduits" is intended to mean all manner of containers and fluid conduits used in the beverage industry for the preparation and storage of beverages, especially the wine, beer, soft drink, juice industries.
  • Representative examples of such containers and fluid conduits include fermentation chambers and conduits used in apparatuses for preparation (e.g. fermenting), storage and dispensing of beer and wine. Further examples include storage vats for beer, wine, and precursors thereof. Also included are containers, and all parts of dispensers of soft drinks, milk, juices, and other beverages that come in to contact with the soft drink, milk, juice or other beverage.
  • the present invention provides coated marine articles and methods for preparing such coated articles.
  • the term "marine articles” denotes articles that come into contact with seawater or fresh water (e.g., lake, pond, river or stream) water, including boats and articles of boating equipment. Marine articles also include fresh and salt water aquariums and aquarium articles.
  • the invention provides boats having on or more surfaces modified with the coatings of the invention. Preferably coating of the invention is applied at least to the parts of the boat in contact with the water, including the hull below the waterline, the keel, the rudder, and, if present, propeller and/or centerboard.
  • Boats include without limitation wood, fiberglass, metal and other polymer hull water craft, regardless of size.
  • Articles of boating equipment include those articles normally found on boats, for example oars, life vests, sails, and the like.
  • Aquarium articles include articles that are found in fresh and/or salt water aquariums, including decorative artificial plants, novelties and the like, as well as water conducting surfaces of pumps that circulate water in the aquarium, and filter media for such pumps.
  • the present invention provides coated plumbing articles and methods for the preparation of such coated articles.
  • Articles of plumbing include, for example, metal, glass or plastic pipes and associated fittings and couplings that are used to transfer fresh water or waste water (e.g., sewage).
  • Biomolecule resistance to adso ⁇ tion can be measured by a static soak test using IgG protein.
  • the protein solution is prepared with phosphate buffered saline (PBS), purchased from Sigma Chemical Company, St. Louis. Mo (Sigma 1-5523).
  • Goat gamma globulin also obtained from Sigma Chemical Company (Sigma 1-5523) is used at a concentration of 1 mg/ml.
  • I-goat anti(rabbit IgG) is purchased from NEN Life
  • Protein bound sample (cpm / 13.3 cm 2 ) * (1000 ⁇ g IgG / total mean cpm) This quantity is reported as protein bound in units of ⁇ g per cm of article surface (a 13 mm disk has an area of 1.33 cm 2 ). At least duplicates are run for each sample tested. Typical values found for porous articles, such as low-binding commercial PVDF membranes, such as Durapore membranes, are in the 15 ⁇ 4 ⁇ g/cm 2 range. In contrast, competitive PVDF membranes, such as Fluorodyne ® membranes from Pall co ⁇ oration, are in the 47 ⁇ 19 ⁇ g/cm 2 range.
  • Biomolecule resistance can be determined according to the BSA- 2% Ponseau S test described in Example 7, infra.
  • samples of articles are either (1) heated to 135°C for two hours in an oven; (2) held in a 121°C steam autoclave for one hour; or (3) for materials that melt at temperatures over 100°C, heated to 100°C for two hours in an oven, and then tested as described above.
  • TOC Total Organic Carbon
  • Three article samples having the same area of coated surface are placed in a pre- cleaned 40 ml TOC vial.
  • the vial is covered by a suitable hydrophobic porous sheet, such as GVX (hydrophobic PVDF membrane) and is secured by a rubber band.
  • the vial is then autoclaved at 126°C for 1 hour. After cooling the vial is removed.
  • the GVX is removed and 40.0 ml of fresh MilliQ water is added, and the vial immediately capped with its pre-cleaned, Teflon lined septum cap.
  • the samples are allowed to extract overnight (minimum 16 hrs).
  • the extracts are then analyzed for TOC levels by a Sievers 800 TOC analyzer.
  • the raw PPM results are corrected for the blank, which is an empty vial that was also autoclaved and extracted overnight.
  • These ppm TOC results are converted to ⁇ g C per cm 2 by multiplying by 40 ml and dividing by 52.05 cm 2 .
  • TOC/NVR Total Organic Carbon / Non-Volatile Residue
  • a sample of a coated article having approximately 8 ft 2 of coated surface is wrapped in GVX.
  • the sample is then autoclaved at 126°C for 1 hour. After cooling the membrane is removed from the GVX and added to 800 ml of fresh MilliQ ® water in a pre-cleaned 1 L graduated cylinder such that the coated article surface is completely submerged.
  • the cylinder is capped with a layer of aluminum foil and the sample is allow to extract overnight (minimum 16 hours). The sample is then removed. Aliquots of the extracts are then analyzed for TOC (40 ml) and NVR (200-600 ml) by standard methods.
  • Flow Time is a method to measure permeability, then exposed to 0.1 NaOH for two hours at ambient temperature and re-tested for Flow Time.
  • Flow Time testing is done by passing a measured amount of liquid through a membrane at a set pressure and measuring the time for complete passage.
  • the ratio of Flow Times after to before exposure is a measure of the effect of caustic on the article. A higher ratio shows more effect. A ratio of 1 shows no effect.
  • a caustic resistant article is one that remains wettable after this exposure and has a ratio of flow times after exposure to that before exposure of less than about 1.5.
  • the samples are wetted out with water and placed in a filter holder with a reservoir for holding a volume of water and attached to a vacuum pump.
  • One application of the methods of the invention is in the formation of coated porous membranes.
  • Method for the preparation of coated membranes are disclosed in U.S. Provisional Application Ser. No. No.60/287,172 filed April 27, 2001, the contents of which are inco ⁇ orated herein by reference.
  • the following examples illustrate the preparation and testing of some such embodiments.
  • the membranes After emerging from the UV unit, the membranes are removed from the sandwich and immediately placed in methanol, where they are washed by swirling for 15 minutes. Next, they are washed in MilliQ ® water for 15 minutes. Following this washing procedure they are allowed to air dry. The membranes are weighed again, and the % weight add-on per membrane is calculated as the added weight divided by the initial weight multiplied by 100. For this example, the weight add-on was 4.4%.
  • the modified membrane displayed a water flow time increase of 25%.
  • the total organic carbon extractables were measured as 0.646 micrograms/square centimeter.
  • the wetting time and protein binding are given in Table 3 below:
  • Wetting time was measured by dropping a 47 mm disk horizontally into water and timing the appearance of complete wetting through the disk.
  • PVDF membranes were modified as described in Example 1 using different monomers with DMAm and MBAm, as shown Table 4 below: Table 4
  • Rolls of surface modified membrane were prepared by sequentially passing hydrophobic O.l ⁇ m pore sized membrane at various speeds through a wetting pan containing an aqueous solution composed of various concentrations of N,N- dimethylacrylamide (DMAm), N,N'-methylenebisacrylamide (MBAm), diacetoneacrylamide (DACAm), and tri(propyleneglycol)methyl ether (TPM, constant 20%), exposing to UV radiation from both sides using four Fusion UV Systems F600 lamps while sandwiched between polyethylene film, rinsing in a tank of methanol followed by a tank of water, and drying over a vacuum drum while impinging with 115 °C dry air.
  • the various conditions employed and results are given in Table 5 below. Controls in Lines 1 and 2 are included to demonstrate the effect of mixing monomers on the thermal stability of protein binding.
  • modified membrane such as those of the present invention
  • a cleaning method that will remove low molecular weight species and unreacted monomers, as well as unbound oligomers and polymeric species. This may be done by sufficiently exhaustive extraction with a liquid which will solvate these materials.
  • an economic price to be paid as the extraction time is increased, and it is therefore desirable that the extraction time be minimized.
  • modified membranes of the prior art do not show reduced extractables despite lengthy washing or soaking, if they are subsequently autoclaved. While not wishing to be bound by a particular theory, it is believed that this may be due to hydrolytic breakdown products of the modification resulting from autoclaving, which are extracted subsequently. It can be seen that it would be desirable to have a modified membrane or porous media that had a stable extractables level after exposure to heat, for example autoclaving, or exposure to highly alkaline liquids. It is a significant attribute of the membranes of the present invention that they can be efficiently cleaned up to very low levels of extractables, levels lower than membranes of the prior art.
  • Figure 1 illustrates the results from a test to compare extractable levels of membranes of the prior art and those of the present invention.
  • Sets of both membranes were subjected to a post-manufacturing soak at conditions designed to remove significant amounts of any extractables present. Sub-sets of each type were soaked for different times in order to determine the effect of increasing soak time on extractables removal.
  • Samples of commercial PVDF microporous membrane (Durapore®, Millipore Co ⁇ oration, Bedford, MA) were soaked in 80°C water for times as shown in Figure 1. After each time interval, samples were removed and tested in the TOC method for determining extractables levels.
  • Figure 1 shows that TOC extractables are between about 2 to 5 micrograms per square centimeter. The level of extractables was unaffected by the 80°C soak time. This indicates a limit to any improvement for these membranes.
  • Membranes of the present invention were soaked in methanol for times as shown in Figure 1, and TOC extractables were determined as described above.
  • the black squares denote Durapore® and the grey triangles, inverted triangles and circles denote independent runs of identical membranes of the invention.
  • TOC extractables are approximately an order on magnitude lower, about 0.2 to 0.4 micrograms per square centimeter.
  • Figure 1 which illustrates the results of Example 1 , clearly shows the beneficial effect of the present invention.
  • Figure 2 the results from three modifications of the same base membrane are shown. Modification of two sets of samples with crosslinked polyacrylamide from a single monomer (N, N- dimethylacrylamide (DMAm) in one case and diacetone acrylamide (DACAM) in the other) and crosslinker monomer (methylene bis-acrylamide (MBAm)) have good, that is low, protein adso ⁇ tion as made. When samples of these modified membranes are heated to 135°C for two hours in an oven and then tested, protein adso ⁇ tion was markedly higher, by approximately 4-10 times the as-made value.
  • N N- dimethylacrylamide
  • DACAM diacetone acrylamide
  • MBAm methylene bis-acrylamide
  • a separate sample of each was held in a 121 °C steam autoclave for one hour and then tested for protein adso ⁇ tion.
  • the DMAm sample was much higher than the as-made value, while the DACAm sample had about the same value.
  • the membrane modified with a mixture of DMAm and DACAm monomers showed a negligible effect from the two hour 135°C heating or the autoclaving.
  • the as-made protein adso ⁇ tion of the multipolymer modified membrane was lower than those of the single monomer modified membranes.
  • a heat stable biomolecule resistant surface is one that has no increase or a small increase in biomolecule adso ⁇ tion after heat exposure. More specifically, a heat stable biomolecule resistant surface is one which, after exposure to heat as described herein, has less than about twice the IgG adso ⁇ tion of the same surface prior to heat exposure, as measured by the IgG test described herein.
  • biomolecule resistance is measured with the IgG test. Representative heat exposures are done with dry heat at 135°C for 2 hours, and with wet heat at 124°C for 1 hour.
  • a heat stable biomolecule resistant surface is one that has less than about twice the IgG adso ⁇ tion of the unexposed-to-heat surface.
  • P values for the monomers were calculated using ChemPlusv software (HyperCube, Inc., Waterloo, Ont.). Monomer P values were then used to calculate a combined P value for the crosslinked multipolymers of Examples 1 and 3. The combined values were the sum of the mass fraction of the monomers times its P value. The combined P value is a measure of the hydrophilic nature of the resulting polymer, the higher the value, the less hydrophilic is the polymer.
  • Table 8 shows the combined P values, the protein binding after dry heat (2 hours at 135°C) and after autoclave (1 Hour at 124°C steam) exposure. In all the examples in this Table, N,N-methylene bis-acrylamide is the crosslinking monomer. Table 8
  • Hydrosart 0.2 ⁇ cellulose membrane was removed from a Sartocon stack. The ethanol was washed out with MilliQ ® water. After 3 washes with excess MilliQ ® water, a sample of membrane was dried and analyzed by infrared. IR and Scanning Electron Microscopy indicated the membrane was composed of regenerated cellulose on a support of cellulose paper.
  • the washed, but not dried membrane was subjected to the alkaline stability test.
  • the ratio of flow times after to before base treatment was 1.06. This indicates that, according to this criterion, the membrane is alkaline stable.
  • the membrane was tested for protein binding using the standard IgG protocol. The values were:
  • Sartobran P 0.2 ⁇ cellulose membrane was removed from a Sartocon stack. The membrane was washed with MilliQ ® water. After 3 washes with excess MilliQ ® water, a sample of membrane was dried and analyzed by infrared. IR and Scanning Electron Microscopy indicated the membrane was composed of cellulose acetate on a support of polyethylenete ⁇ hthalate.
  • A is: 62 ⁇ grams/cm 2 2 hours 135° C dry heat; 64 ⁇ grams/cm 2
  • the present invention provides methods for preparing an article having the caustic resistant, heat stable biomolecule resistant multipolymer surface described herein.
  • the methods comprise contacting the surface of the article with a reactant solution containing: (1) at least two monofunctional monomers selected from the group consisting of acrylamides, methacrylamides, and N-vinyl pyrrolidones; and
  • polyfunctional monomer selected from the group consisting of polyfunctional acrylamides, polyfunctional methacrylamides and diacroylpiperazines; said solution optionally further comprising one or more polymerization initiators; polymerizing said monomers to form the heat stable biomolecule resistant surface on the surface of the article, and optionally washing the article.
  • Example 7 Adsorption of coated articles having nonporous surfaces as determined by BSA-
  • Dense films of Nylon 66 and polyethylene, as well as polystyrene from a weighing boat and a piece of Nylon nonwoven material were modified with surface coatings of the invention and their propensity to absorb bovine serum albumin(BSA) were determined as described below. It will be appreciated that myriad articles of various shapes can be fabricated from these polymers, and also that other polymers apparent to those of skill in the art can be similarly modified.
  • Nylon 66 and polyethylene(PE) dense films were treated with either water or a solution of N,N-Dimethylacrylamide (DMAm), Diacetoneacrylamide (DACAm), and Methylenebisacrylamide (MBAm).
  • DAm N,N-Dimethylacrylamide
  • DACAm Diacetoneacrylamide
  • MAm Methylenebisacrylamide
  • a polystyrene weighing boat was cut to provide another flat sample about 9 mils thick and was treated in a similar manner, as was a piece of Nylon nonwoven 8 mils thick.
  • the samples were covered with another piece of PE film so that a thin film of water or the solution covered the Nylon, PE, and polystyrene samples.
  • the samples were then placed in a tray, and passed through an electron beam exposure system at a dosage of 5 megarads. This exposure initiates polymerization and grafts the resulting copolymers to the surface of the film samples.
  • the samples were then washed with water and allowed to dry. The samples were cut in half, and one half was placed in an oven at 100 degrees centigrade for 2 hours.
  • a solution of BSA in pH 7.4 phosphate buffered saline was prepared.
  • the unheated and heated film samples, along with control samples were placed in the BSA solution for 16 hours.
  • the positive control was an unmodified polyvinylidene fluoride(PVDF) membrane and the negative control was the same membrane surface modified with a similar solution to that used for the film samples.
  • PVDF polyvinylidene fluoride

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Laminated Bodies (AREA)
  • Paints Or Removers (AREA)

Abstract

La présente invention concerne des articles présentant un revêtement de surface qui comprend un multipolymère réticulé avec une combinaison supérieure de propriétés. Parmi ces propriétés, il convient de citer des propriétés d'adsorption résistante aux biomolécules thermiquement stables, des propriétés de résistance aux solutions fortement alcalines et deux niveaux de matière pouvant être extraite.
PCT/US2002/013194 2001-04-27 2002-04-26 Revetement reticule multipolymere WO2003008011A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE60212965T DE60212965T2 (de) 2001-04-27 2002-04-26 Vernetzte multipolymere beschichtung
EP02729002A EP1390087B1 (fr) 2001-04-27 2002-04-26 Revetement reticule multipolymere
JP2003513615A JP4192091B2 (ja) 2001-04-27 2002-04-26 架橋されたマルチポリマーコーティング

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2717201P 2001-04-27 2001-04-27
US60/27,172 2001-04-27

Publications (1)

Publication Number Publication Date
WO2003008011A1 true WO2003008011A1 (fr) 2003-01-30

Family

ID=21836101

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/013194 WO2003008011A1 (fr) 2001-04-27 2002-04-26 Revetement reticule multipolymere

Country Status (2)

Country Link
JP (1) JP2009034999A (fr)
WO (1) WO2003008011A1 (fr)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553417B2 (en) 2005-12-30 2009-06-30 3M Innovative Properties Company Functionalized substrates
US7883767B2 (en) 2004-09-30 2011-02-08 Mcmaster University Composite material comprising layered hydrophilic coatings
US8356717B2 (en) 2007-10-11 2013-01-22 3M Innovative Properties Company Hydrophilic porous substrates
US8551894B2 (en) 2008-09-19 2013-10-08 3M Innovative Properties Company Ligand graft functionalized substrates
US8846203B2 (en) 2008-05-30 2014-09-30 3M Innovative Properties Company Method of making ligand functionalized substrates
CN104284942A (zh) * 2012-04-27 2015-01-14 兴和株式会社 稳定的人工晶体用聚合性紫外线吸收色素
US8945896B2 (en) 2010-02-18 2015-02-03 3M Innovative Properties Company Ligand functionalized polymers
US9259689B2 (en) 2009-06-23 2016-02-16 3M Innovative Properties Company Functionalized nonwoven article
US9758547B2 (en) 2010-03-03 2017-09-12 3M Innovative Properties Company Ligand functionalized polymers
CN107208018A (zh) * 2014-12-22 2017-09-26 美国圣戈班性能塑料公司 细胞捕获系统和方法
CN107208014A (zh) * 2014-12-22 2017-09-26 美国圣戈班性能塑料公司 细胞捕获系统和方法
CN107208026A (zh) * 2014-12-22 2017-09-26 美国圣戈班性能塑料公司 气体可渗透性材料
CN107208027A (zh) * 2014-12-22 2017-09-26 美国圣戈班性能塑料公司 在受控环境中培养细胞的系统
US10801649B2 (en) 2017-09-28 2020-10-13 Saint-Gobain Performance Plastics Corporation Fuel tubings and methods for making and using same
CN113512219A (zh) * 2021-05-27 2021-10-19 东南大学 一种颜色可调的隐形眼镜材料及其制备方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2738306B1 (fr) * 2011-07-26 2017-06-07 Kyoto Prefectural Public University Corporation Fibre inhibant la production d'un facteur pathogène et procédé de production de cette dernière
JP6492368B2 (ja) * 2013-10-30 2019-04-03 興和株式会社 重合性紫外線吸収色素の製造方法
WO2020075713A1 (fr) * 2018-10-09 2020-04-16 Jnc株式会社 Composition de revêtement pour l'hydrophilisation d'un film microporeux, et film microporeux hydrophile

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475807A2 (fr) * 1990-08-30 1992-03-18 Terumo Kabushiki Kaisha Matériau pour le recouvrement des plasies
US5290548A (en) * 1987-04-10 1994-03-01 University Of Florida Surface modified ocular implants, surgical instruments, devices, prostheses, contact lenses and the like
US5543054A (en) * 1993-11-24 1996-08-06 Millipore Corporation Method and apparatus for covalent immobilization of charge- conjugated carbohydrate molecules

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0259030A (ja) * 1988-08-25 1990-02-28 Mitsubishi Rayon Co Ltd 耐熱親水化多孔質膜及びその製造方法
JP3168036B2 (ja) * 1990-10-19 2001-05-21 三菱レイヨン株式会社 大孔径多孔質ポリエチレン中空糸膜、その製造方法及び親水化多孔質ポリエチレン中空糸膜
JPH04192091A (ja) * 1990-11-27 1992-07-10 Omron Corp Ｉｃカード装置
JP3130996B2 (ja) * 1991-02-08 2001-01-31 三菱レイヨン株式会社 大孔径多孔質ポリプロピレン中空糸膜、その製造法及び親水化多孔質ポリプロピレン中空糸膜
JP3256282B2 (ja) * 1991-07-18 2002-02-12 三井化学株式会社 硬化性組成物、水性ゲル及びそれらの用途
JPH09146052A (ja) * 1995-11-21 1997-06-06 Kuraray Co Ltd 含水性眼用レンズ材料
JPH1080477A (ja) * 1996-09-09 1998-03-31 Toray Ind Inc 血液処理用モジュール
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
WO2002087734A1 (fr) * 2001-04-27 2002-11-07 Millipore Corporation Nouvelles membranes recouvertes et autres articles
US7073671B2 (en) * 2002-06-07 2006-07-11 Millipore Corporation Microporous membrane substrate having caustic stable, low protein binding surface

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290548A (en) * 1987-04-10 1994-03-01 University Of Florida Surface modified ocular implants, surgical instruments, devices, prostheses, contact lenses and the like
EP0475807A2 (fr) * 1990-08-30 1992-03-18 Terumo Kabushiki Kaisha Matériau pour le recouvrement des plasies
US5543054A (en) * 1993-11-24 1996-08-06 Millipore Corporation Method and apparatus for covalent immobilization of charge- conjugated carbohydrate molecules

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7883767B2 (en) 2004-09-30 2011-02-08 Mcmaster University Composite material comprising layered hydrophilic coatings
US7553417B2 (en) 2005-12-30 2009-06-30 3M Innovative Properties Company Functionalized substrates
US8356717B2 (en) 2007-10-11 2013-01-22 3M Innovative Properties Company Hydrophilic porous substrates
US9314746B2 (en) 2007-10-11 2016-04-19 3M Innovative Properties Company Hydrophilic porous substrates
US9650470B2 (en) 2008-05-30 2017-05-16 3M Innovative Properties Company Method of making ligand functionalized substrates
US8846203B2 (en) 2008-05-30 2014-09-30 3M Innovative Properties Company Method of making ligand functionalized substrates
US10017461B2 (en) 2008-05-30 2018-07-10 3M Innovative Properties Company Method of making ligand functionalized substrates
US9302208B2 (en) 2008-09-19 2016-04-05 3M Innovative Properties Company Ligand graft functionalized substrates
US8551894B2 (en) 2008-09-19 2013-10-08 3M Innovative Properties Company Ligand graft functionalized substrates
US9492771B2 (en) 2008-09-19 2016-11-15 3M Innovative Properties Company Ligand graft functionalized substrates
US9259689B2 (en) 2009-06-23 2016-02-16 3M Innovative Properties Company Functionalized nonwoven article
US9296847B2 (en) 2010-02-18 2016-03-29 3M Innovative Properties Company Ligand functionalized polymers
US8945896B2 (en) 2010-02-18 2015-02-03 3M Innovative Properties Company Ligand functionalized polymers
US9758547B2 (en) 2010-03-03 2017-09-12 3M Innovative Properties Company Ligand functionalized polymers
US10526366B2 (en) 2010-03-03 2020-01-07 3M Innovative Properties Company Ligand functionalized polymers
US10005814B2 (en) 2010-03-03 2018-06-26 3M Innovative Properties Company Ligand functionalized polymers
RU2635918C1 (ru) * 2012-04-27 2017-11-17 Кова Компани, Лтд. Стабильный полимеризуемый уф-поглощающий краситель для интраокулярной линзы
CN104284942A (zh) * 2012-04-27 2015-01-14 兴和株式会社 稳定的人工晶体用聚合性紫外线吸收色素
US9365501B2 (en) 2012-04-27 2016-06-14 Kowa Company, Ltd. Stable polymerizable UV-absorbing colorant for intraocular lens
CN107208027A (zh) * 2014-12-22 2017-09-26 美国圣戈班性能塑料公司 在受控环境中培养细胞的系统
EP3237595A4 (fr) * 2014-12-22 2018-05-23 Saint-Gobain Performance Plastics Corporation Système de capture de cellules et procédés
CN107208026A (zh) * 2014-12-22 2017-09-26 美国圣戈班性能塑料公司 气体可渗透性材料
CN107208014A (zh) * 2014-12-22 2017-09-26 美国圣戈班性能塑料公司 细胞捕获系统和方法
CN107208018A (zh) * 2014-12-22 2017-09-26 美国圣戈班性能塑料公司 细胞捕获系统和方法
US10711235B2 (en) 2014-12-22 2020-07-14 Saint-Gobain Performance Plastics Corporation Gas permeable material
CN107208014B (zh) * 2014-12-22 2021-06-04 美国圣戈班性能塑料公司 细胞捕获系统和方法
US11142736B2 (en) 2014-12-22 2021-10-12 Saint-Gobain Performance Plastics Corporation Gas permeable material
US10801649B2 (en) 2017-09-28 2020-10-13 Saint-Gobain Performance Plastics Corporation Fuel tubings and methods for making and using same
CN113512219A (zh) * 2021-05-27 2021-10-19 东南大学 一种颜色可调的隐形眼镜材料及其制备方法
CN113512219B (zh) * 2021-05-27 2022-05-31 东南大学 一种颜色可调的隐形眼镜材料及其制备方法

Also Published As

Publication number Publication date
JP2009034999A (ja) 2009-02-19

Similar Documents

Publication Publication Date Title
EP1390087B1 (fr) Revetement reticule multipolymere
JP2009034999A (ja) 架橋されたマルチポリマーコーティング
JP4677230B2 (ja) 耐腐食性かつ低い蛋白質結合性表面を有する多孔質膜基体
Zhang et al. Preparation and characterization of hydrophilic modification of polypropylene non-woven fabric by dip-coating PVA (polyvinyl alcohol)
Lien et al. A zwitterionic interpenetrating network for improving the blood compatibility of polypropylene membranes applied to leukodepletion
Nie et al. Acrylonitrile-based copolymer membranes containing reactive groups: effects of surface-immobilized poly (ethylene glycol) s on anti-fouling properties and blood compatibility
ES2275872T3 (es) Procedimiento de reduccion de la propension a la adsorcion de moleculas o de celulas biologicas sobre una superficie.
US20220251519A1 (en) Concentration membrane, concentration device, concentration system, and concentration method for biological particles, and method for detecting biological particles
Wu et al. Surface modification of a PVDF membrane by cross-linked collagen
WO2021090217A1 (fr) Membranes de polyéthersulfone modifiée en surface et leur procédé de fabrication
WO2021090215A1 (fr) Membranes de polyéthersulfone modifiées en surface et leur procédé de fabrication
EP1779922A1 (fr) Nouvelles membranes revêtues et autres articles
JP2021023928A (ja) 分離膜およびその製造方法
CN112334219B (zh) 用于聚合物平片膜的uv接枝方法
JPH03292884A (ja) 細胞培養方法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003513615

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002729002

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002729002

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2002729002

Country of ref document: EP